Phase 3 N=4 Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss
Spontaneous Abortion in First Trimester
Primary: Patient Enrollment — 2; 2 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=513 Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE
Respiratory Failure
Primary: Microaspiration as Measured by Tracheal Amylase — 13,086; 15,298 U/L — p=0.432
N/A N=267 Taking Charge of Systemic Sclerosis
Scleroderma
Primary: Change in Managing Symptoms Scale on the PROMIS® Self-efficacy Short Form 8 — 0.35; 0.94; 0.50; 1.49 units on a scale — p=0.87
N/A N=99 Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
Schizophrenia
Primary: Neurocognition — 42.02; 41.92; 41.94 score on a scale
Phase 3 N=299 A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
Hepatic Encephalopathy
Primary: Time To The First Breakthrough Overt HE Episode — 13; 20; 4; 23 events — p=<0.0001
Phase 3 N=322 Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy
Hepatic Encephalopathy
Primary: Number Of Participants Reporting A Non-serious Adverse Event Or A Serious Adverse Event — 78; 15; 158; 49 Participants
N/A N=38 Collaborative-care Rehabilitation After Dysvascular Amputation
Diabetes Complications · Peripheral Arterial Disease
Primary: Timed Up-and-Go Test — 19.4; 20.7; 18.2; 18.8 seconds — p=0.87
Phase 2 N=69 Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Primary Sjögren's Syndrome
Primary: Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) — 12.0; 11.8; 10.6; 11.0 units on a scale — p=0.397
N/A N=40 The Effects of a Jump Rope Exercise Program on Vascular Health, Inflammatory Markers in Prehypertensive Adolescent Girls
Prehypertension · Blood Pressure · Abdominal Obesity
Primary: Arterial Stiffness — 8.1; 7.4 m/s
N/A N=78 Electromyostimulation and Strength Walking for Knee Injuries
Knee Injury
Primary: Lower Extremity Muscle Strength- Extension — 27.5; 32.6; 32.1; 24.3 Kilograms
Phase 3 N=265 Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
Proctitis · Proctosigmoiditis
Primary: Percentage of Participants Who Achieved Remission — 38.3; 25.8 percentage of participants — p=0.0324
N/A N=69 Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.
Heart Failure
Primary: Verbal Memory Score Change — -0.08; -0.08; 0.18; -0.47 score on a scale
Phase 2 N=13 Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
Mucositis
Primary: Adherence to Treatment — 4; 1 Participants
N/A N=46 Reducing Post-Op Pain After Sacrospinous Ligament Colpopexy
Pain
Primary: Postoperative Gluteal Pain — 3.6; 4.0; 2.0; 2.0 units on a scale — p=0.83
Phase 4 N=66 Study EvAluating Genotypes While Using Lucentis 2
Age-Related Macular Degeneration
Primary: To Determine the Genotype at VEGF and HTRA1 SNPs of Patients Gaining ≥ 0 Letters of Visual Acuity in Response to Ranibizumab Treatment Over a 4 Month Period.